| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/12/2011 | EP2271658A1 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
| 01/12/2011 | EP2271649A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof |
| 01/12/2011 | EP2271648A1 Isoxazoline linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparattion thereof |
| 01/12/2011 | EP2271647A1 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 01/12/2011 | EP2271646A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/12/2011 | EP2271645A1 Compounds and compositions as kinase inhibitors |
| 01/12/2011 | EP2271643A1 Compounds |
| 01/12/2011 | EP2271631A2 Inhibitors of protein kinases |
| 01/12/2011 | EP2271630A1 Compounds and compositions as protein kinase inhibitors |
| 01/12/2011 | EP2271626A1 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors |
| 01/12/2011 | EP2271620A1 Compositions and methods for inhibition of hepatocyte growth factory receptor c-met signaling |
| 01/12/2011 | EP2271618A1 Pharmaceutical compounds |
| 01/12/2011 | EP2271370A2 Compositions and methods for diagnosing and treating melanoma |
| 01/12/2011 | EP2271359A2 Camptothecin-binding moiety conjugates |
| 01/12/2011 | EP2271352A1 Compositions and methods for treatment of neoplastic disease |
| 01/12/2011 | EP2271350A1 Compositions and methods for immunotherapy |
| 01/12/2011 | EP2271341A1 Specific inhibitors for vascular endothelial growth factor receptors |
| 01/12/2011 | EP2271339A1 On01910. na enhances chemotherapeutic agent activity in drug-resistant tumors |
| 01/12/2011 | EP2271325A1 Methods and use of inducing apoptosis in cancer cells |
| 01/12/2011 | EP2027156B1 Hepatocyte growth factor (hgf) binding proteins |
| 01/12/2011 | EP1996591B1 Spiroindolinone derivatives |
| 01/12/2011 | EP1865058B1 Anti-cd-20 monoclonal antibody |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | EP1401458B1 Composition consisting of phy906 and chemotherapeutic agents |
| 01/12/2011 | EP1302541B1 Method for recognizing bacterial DNA |
| 01/12/2011 | EP1272206B1 A chicken II GnRH analog for use in reducing tumor cell growth |
| 01/12/2011 | EP1109831B1 Cyctotoxic peptides modified by bulky or lipophilic moieties |
| 01/12/2011 | EP1003782B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/12/2011 | CN201701876U Membrane separating system for extracting bioactive compositions from bamboo leaves |
| 01/12/2011 | CN1985994B Improved enteric medicine composition with mycophenolate |
| 01/12/2011 | CN1980898B Nucleoside derivatives and therapeutic uses therof |
| 01/12/2011 | CN1872030B Drop pills of anticancer drugs, and preparation method |
| 01/12/2011 | CN1856313B Therapeutic compounds |
| 01/12/2011 | CN1688605B Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes |
| 01/12/2011 | CN101946003A Anti-adam-15 antibodies and utilization of the same |
| 01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
| 01/12/2011 | CN101945892A Methods and agents for improving targeting of cd138 expressing tumor cells |
| 01/12/2011 | CN101945875A Azaindolizines and methods of use |
| 01/12/2011 | CN101945874A 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 01/12/2011 | CN101945870A 5-anilinoimidazopyridines and methods of use |
| 01/12/2011 | CN101945867A Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 01/12/2011 | CN101945852A Azetidine derivatives, their preparation and their application in therapy |
| 01/12/2011 | CN101945671A Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 01/12/2011 | CN101945670A Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 01/12/2011 | CN101942445A Nucleic acid aptamer derivative and application thereof in preparation of medicament carrier |
| 01/12/2011 | CN101942441A Structure and application of siRNA for suppressing proliferation and metastasis of human lung cancer cells |
| 01/12/2011 | CN101942026A Long-acting interferon fusion protein and application thereof |
| 01/12/2011 | CN101942020A Streptavidin/interleukin-7 fusion protein |
| 01/12/2011 | CN101942017A Novel tumor marker |
| 01/12/2011 | CN101942012A Polypeptide for preventing and treating angiogenesis and application thereof |
| 01/12/2011 | CN101941994A Method for preparing selenium manno-oligosaccharide |
| 01/12/2011 | CN101941984A 2,1,3-thiazole and naphthalimide compound and application thereof in tumor cell |
| 01/12/2011 | CN101941977A Antitumoral analogs of lamellarins |
| 01/12/2011 | CN101941970A Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 01/12/2011 | CN101941967A Salt of 13a-(S) deoxidized tylophorinine, preparation method, pharmaceutical composition and application thereof |
| 01/12/2011 | CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/12/2011 | CN101941953A Nitrogenous heterocyclic substituted hydrazide compounds as well as preparation methods and applications thereof |
| 01/12/2011 | CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry |
| 01/12/2011 | CN101941918A Cassaine alkaloid analogue, preparation method thereof, drug combination and application thereof |
| 01/12/2011 | CN101941914A Hydroxyl whole-protection didecyl quaternary ammonium with anti-tumor activity and preparation method thereof |
| 01/12/2011 | CN101941077A Method for preparing magnetic metal iron-encapsulated fullerene carbon spheres |
| 01/12/2011 | CN101940797A Cladded nuclide labeled protein microsphere, preparation method and applications thereof |
| 01/12/2011 | CN101940796A Preparation of gene immunization treating tumor used for vein |
| 01/12/2011 | CN101940794A Csk binding protein inhibitor and application thereof |
| 01/12/2011 | CN101940793A Hydroxypropyl-beta-cyclodextrin clathrate compound of cantharidin and cantharis extractive and preparation method thereof |
| 01/12/2011 | CN101940792A PCL-b-PEG-b-PCL carried hydrophobic medicine polymer vesica as well as preparation method and application thereof |
| 01/12/2011 | CN101940791A Dually-targeted pH-sensitive antineoplastic drug carrier material as well as preparation and application thereof |
| 01/12/2011 | CN101940783A Application of DNAzyme in preparing medicines for enhancing tumor chemotherapy sensitivity |
| 01/12/2011 | CN101940782A Lanreotide long-acting injection microsphere preparation and preparation method thereof |
| 01/12/2011 | CN101940738A Coix seed anticancer Chinese medicament and preparation method thereof |
| 01/12/2011 | CN101940708A Traditional Chinese medicinal preparation for curing malignant pleural effusion |
| 01/12/2011 | CN101940706A Orally taken medicament for treating mammary cancer |
| 01/12/2011 | CN101940700A Dai nationality medicine for treating rheumatism |
| 01/12/2011 | CN101940699A Traditional Chinese medicine for assisting in treating liver cancer |
| 01/12/2011 | CN101940696A Method for preparing Chinese medicinal compound Zengshengping |
| 01/12/2011 | CN101940647A Chinese medicinal herb for treating tympanites (syndromes) |
| 01/12/2011 | CN101940644A Ginseng-hedyotis diffusa oral liquid and preparation method thereof |
| 01/12/2011 | CN101940643A Medicament for treating gastric cancer and esophagus cancer |
| 01/12/2011 | CN101940615A New preparation method of Isodon excisa total diterpene |
| 01/12/2011 | CN101940595A Calf spleen extract for treating tumors |
| 01/12/2011 | CN101940581A Targeted medicinal composition for treating tumors |
| 01/12/2011 | CN101940571A Anti-angiogenic agents and methods of use |
| 01/12/2011 | CN101940570A Composite of ligustrazine phosphate and danshensu and application thereof |
| 01/12/2011 | CN101940569A Medicament composition containing sorafenib, artemisinin and artemisinin derivative and application thereof in preparing medicament for treating cancer |
| 01/12/2011 | CN101940565A Application of T-2 toxin in preparing drug for treating prostatic cancer |
| 01/12/2011 | CN101940553A Folic acid-vincristine targeted and slow-released nano-microspheres, prepared method and application thereof |
| 01/12/2011 | CN101940548A Oral fluorouracil emulsion and preparation method thereof |
| 01/12/2011 | CN101619316B Functional gene Rdr-onc sequence of rana chensinensis onconase sample, construction method, amino acid sequence thereof and application thereof |
| 01/12/2011 | CN101612401B Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/12/2011 | CN101537146B Chinese medicine for treating carcinoma of colon |
| 01/12/2011 | CN101513530B Polyhydroxyalkanoate (PHA) targeted carrier, drug-loading nano-particle and preparation methods and application thereof |
| 01/12/2011 | CN101513395B Taxol double-layer soft capsule oral preparation medicament |
| 01/12/2011 | CN101480377B Method for preparing tumor enzyme-targeted nano medicine-carrying polymer microsphere |
| 01/12/2011 | CN101390826B Magnetic tumour target polymer nano vesicle and preparation method thereof |
| 01/12/2011 | CN101367801B Preparation method for pyrrol-hexahydric N heterocycle hydroxyl morpholine derivants, and medical uses thereof |
| 01/12/2011 | CN101343268B Thiazole couplet pyrazolone series compound and application of the same as Bcl-2 family protein antagonist |
| 01/12/2011 | CN101333215B Method for synthesizing sunitinib alkali |
| 01/12/2011 | CN101327214B Medicine use of isoquinoline alkaloids as tissue factor inhibitor |